BRIDGETTE BERKOWITZ: Open Payments
NPI 1144098617 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 33 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $597 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $112 |
| UCB, Inc. | 5 | $110 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $53 |
| Biogen, Inc. | 2 | $47 |
| CSL Behring | 2 | $46 |
| Cala Health, Inc. | 1 | $39 |
| ACADIA Pharmaceuticals Inc | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Neurelis, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: Leqembi, Fintepla, SPINRAZA, Hizentra, Cala kIQ, NUPLAZID, VYALEV, VALTOCO.
Industry payments across FL — which companies pay providers there.
